Valeant Pharmaceuticals International 10K 2006 Annual report | SEC Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: AAIPharma, accuracy, ActRule, actuarial, AcuDial, administered, admitting, afflicted, agenda, agility, Aliso, Allergan, ANDANo, anguish, antiemetic, Ardea, assay, attend, attended, augment, Australasia, backdating, bDNA, Benefitswith, bifurcation, Biovail, Birsfelden, Bisocard, boycotted, buying, Cambridge, Cap, CaseNo, cataplexy, categorized, CEO, Cephalon, CFO, chilblain, Chilean, choose, CINP, CINV, comparison, contacted, conventional, cooperate, cooperated, curtailed, customary, default, deficiency, delisted, denial, deployment, dietary, differentiate, dissolve, distracting, diversify, driver, dual, East, eighteen, Eisai, EITFIssue, eligible, emotional, endpoint, enrichment, entirety, ERP, ESPP, facilitate, fee, Finacea, flat, Forest, GmbH, graph, GSK, guanosine, heparin, Humacao, hybrid, illustrate, infusion, inquiry, introducing, IssueNo, Jazz, Judicial, Kenneth, King, Korea, lacosamide, Lamictal, Lawson, lean, leg, leverage, LGS, lieu, log, Malaysia, mcg, McKesson, Medicare, Michael, mid, Middle, monoamine, mortgage, mouth, muscle, Mylan, nabilone, narcolepsy, Nasdaq, negligible, neuropathic, neutralize, NM, ofEITF, ofForm, onForm, onset, orderly, ourForm, outsourcing, overexposure, oxybate, paper, partnership, path, pattern, peak, point, postretirement, pre, presence, proceed, prolonged, Pronko, Protamin, pursuit, quality, ratified, reacquire, Reconciliation, reconsideration, regimen, reinstated, repaid, rescission, rosacea, rufinamide, salary, Scheriproct, schizophrenia, Schwarz, sector, seller, Shire, sigma, sixteen, Skinoren, sodium, standing, steady, step, stronger, styledPaul, Subtotal, successor, sudden, suggested, suspended, thisForm, threshold, timeline, TMA, tone, transferee, trauma, twelve, UCB, Ultrabase, unclear, unjust, upfront, Viejo, warehouse, Watson, Winnebago, XR, Xyrem

Removed: adefovir, ago, aircraft, amounted, AMW, artificially, attract, Banc, BDW, began, BID, biological, BNP, bondholder, bromide, build, BWD, Chamber, combine, Commerce, consulting, declare, delivered, device, disbursed, divestiture, Dosimetry, effort, enzyme, erosion, expectation, extended, Fargo, formed, generation, Goldman, great, grow, guanisine, hearing, host, impaired, inception, inflating, initiative, kidney, laser, leave, led, Levovirin, library, LLC, locate, merger, mg, modeling, modification, molecular, motivate, Mutual, organ, past, peg, peginterferon, penetration, physiochemical, placement, President, prodrug, promulgated, radioactive, randy, realign, receiving, recently, recover, relief, remofovir, rendered, replicate, replication, resale, rest, ruled, Russia, screening, sought, SPI, storage, structure, substrate, suffer, team, thereunder, thurman, toxicity, train, transform, tribunal, unlawful, unregistered, unvested, utilizing, Vice, Viratek, Viropharma, vulnerable, Wyeth

Valeant Pharmaceuticals International Inactive 10-K2006 FY Annual report

Content analysis